Bloodstream infections can progress rapidly to sepsis—bringing high costs, high mortality, and lasting effects. In the second episode of this series in collaboration with bioM茅rieux, Luis speaks with Dr. Jeff Cies, Senior Medical Advisor at bioM茅rieux, about how molecular diagnostics are reshaping bloodstream infection diagnosis.
They discuss:
-
Limitations of traditional blood cultures
-
How rapid molecular tests deliver results faster than ever
-
The impact on outcomes, costs, and antimicrobial resistance
-
The role of stewardship programs in maximizing results
-
What the future holds: direct-from-blood testing, nanotechnology, and AI
A powerful look at how innovation in microbiology is changing the fight against sepsis and saving lives.
This episode is sponsored by bioM茅rieux, a global innovator in infectious disease diagnostics.
Guest:
- Dr. Jeff Cies
Links:
Questions? Feedback? Send those to letstalkmicro@outlook.com
Want to support the podcast? Here's how:
Venmo:
Buy me a Ko-fi:
